Literature DB >> 4075318

Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.

M W DeGregorio, O Y King, W M Holleran, B J Wilbur, E C Cadman, A B Deisseroth, J R Wilbur.   

Abstract

Ultrafiltrate and total plasma and cerebrospinal fluid (CSF) platinum concentrations were examined in a patient with neuroblastoma following a 2-hour infusion of 120 mg/m2 of cisplatin. Total plasma platinum was 93.4% bound, while the ultrafiltrate of plasma accounted for the remaining 6.6%. The CSF ultrafiltrate resulted in equivalent concentrations of platinum to total CSF platinum. CSF concentrations were 2.9% of the total plasma platinum and 43.5% of the ultrafiltrate plasma platinum 2 hours after the end of the infusion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075318

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

1.  Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimens.

Authors:  D R Gandara; E A Perez; A Denham; V J Wiebe; M W DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats.

Authors:  S Sugimoto; Y L Yamamoto; S Nagahiro; M Diksic
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.

Authors:  A Olivi; M Gilbert; K L Duncan; B Corden; D Lenartz; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Platinum-based chemotherapy for recurrent CNS tumours in young patients.

Authors:  E Douek; J E Kingston; J S Malpas; P N Plowman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

6.  Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.

Authors:  G Laurell; A Andersson; B Engström; H Ehrsson
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung.

Authors:  Shih-Hsin Hsiao; Wan-Ting Chen; Chi-Li Chung; Yu-Ting Chou; Sey-En Lin; Shiao-Ya Hong; Jer-Hwa Chang; Tzu-Hao Chang; Li-Nien Chien
Journal:  Cancer Med       Date:  2022-03-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.